Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathophysiology of dry eye disease and novel therapeutic targets
Elisabeth M. Messmer
Experimental Eye Research (2022) Vol. 217, pp. 108944-108944
Closed Access | Times Cited: 22

Showing 22 citing articles:

Smart molecules in ophthalmology: Hydrogels as responsive systems for ophthalmic applications
Merve Kulbay, Kevin Y. Wu, Doanh Truong, et al.
Smart Molecules (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 12
Evaluation of Conventional and Hyaluronic Acid-Coated Thymoquinone Liposomes in an In Vitro Model of Dry Eye
Elisa Landucci, Costanza Mazzantini, Maura Calvani, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 578-578
Open Access | Times Cited: 16
Management of inflammation in dry eye disease: Recommendations from a European panel of experts
Elisabeth M. Messmer, Sajjad Ahmad, José Manuel Benítez del Castillo, et al.
European Journal of Ophthalmology (2022) Vol. 33, Iss. 3, pp. 1294-1307
Open Access | Times Cited: 21
Engineering biocompatible carbon dots nano-enzymes hydrogel for efficient antioxidative and anti-inflammatory treatment of dry eye disease
Hailing Yu, Xiao Yu, Yin Huang, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113490-113490
Closed Access
New Eye Drop Formulation Based on Desonide and Xanthan Gum in Dry Eye Disease: Nonclinical Studies
Santa Viola, Luca Rosario La Rosa, Giuseppe De Pasquale, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 235-235
Open Access
Advances in Regenerative Medicine, Cell Therapy, and 3D Bioprinting for Corneal, Oculoplastic, and Orbital Surgery
Kevin Y. Wu, Natalie Kearn, Doanh Truong, et al.
Advances in experimental medicine and biology (2025)
Closed Access
Novel treatments for dry eye syndrome
Esther Roucaute, Marcela Huertas-Bello, Alfonso L. Sabater
Current Opinion in Pharmacology (2024) Vol. 75, pp. 102431-102431
Closed Access | Times Cited: 3
A Water-Free Omega-3 Fatty Acid Eye Drop Formulation for the Treatment of Evaporative Dry Eye Disease: A Prospective, Multicenter Noninterventional Study
Christina Jacobi, Simone Angstmann-Mehr, Anja Lange, et al.
Journal of Ocular Pharmacology and Therapeutics (2022) Vol. 38, Iss. 5, pp. 348-353
Open Access | Times Cited: 14
Cannabinoid-Based Ocular Therapies and Formulations
Sofia M. Saraiva, Lucía Martín‐Banderas, Matilde Durán‐Lobato
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1077-1077
Open Access | Times Cited: 7
Effects of physical activity/exercise on tear film characteristics and dry eye associated symptoms: A literature review
Sergio Navarro‐Lopez, Manuel Moya‐Ramón, Juana Gallar, et al.
Contact Lens and Anterior Eye (2023) Vol. 46, Iss. 4, pp. 101854-101854
Open Access | Times Cited: 6
The Microbiome, Ocular Surface, and Corneal Disorders
Michael J. Zilliox, Charles S. Bouchard
American Journal Of Pathology (2023) Vol. 193, Iss. 11, pp. 1648-1661
Open Access | Times Cited: 6
Effect of N-Acetyl Cysteine in the Treatment of Dry Eye Disease
Huzaifa Malik, Shagufta Parveen, Ijlal Taimoor, et al.
Journal of Health and Rehabilitation Research (2024) Vol. 4, Iss. 3, pp. 1-7
Open Access | Times Cited: 1
Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Dependent Attenuation of Tear Hyperosmolarity and Immune Cell-Driven Inflammation in the Eyes of Patients with Dry Eye Disease
Carl Randall Harrell, Valentin Djonov, Ana Volarevic, et al.
Diseases (2024) Vol. 12, Iss. 11, pp. 269-269
Open Access | Times Cited: 1
Cell Death Pathways in Dry Eye Disease: Insights into Ocular Surface Inflammation
Jiani Li, Xiaorui Bao, Shujia Guo, et al.
The Ocular Surface (2024) Vol. 34, pp. 535-544
Closed Access | Times Cited: 1
Solving STODS—Surgical Temporary Ocular Discomfort Syndrome
Matthew Hirabayashi, Brad P. Barnett
Diagnostics (2023) Vol. 13, Iss. 5, pp. 837-837
Open Access | Times Cited: 1
Aging and dry eye disease
Meiling Xie, Ruihan Yang, Jian Zhu, et al.
Aging Research (2024) Vol. 2, Iss. 1, pp. 9340022-9340022
Open Access
Post-refractive Surgery Dry Eye: A Systematic Review Exploring Pathophysiology, Risk Factors, and Novel Management Strategies
Saif K Dossari
Cureus (2024)
Open Access
Solving STODS - Surgical Temporary Ocular Discomfort Syndrome
Matthew Hirabayashi, Brad P. Barnett
(2022)
Open Access | Times Cited: 2
Nanoliposomes for Sensing Local Osmolarity of the Tear Film on the Corneal Surface
M. Y. Thanuja, Sudhir H. Ranganath, Joseph A. Bonanno, et al.
Journal of Ocular Pharmacology and Therapeutics (2022) Vol. 38, Iss. 8, pp. 549-560
Closed Access | Times Cited: 1
The impact of microbiome alterations on ocular surface diseases
Kaitlin K. Scholand, Ritu Sampige, Adwaita R. Parab, et al.
Elsevier eBooks (2023), pp. 139-157
Closed Access
Role of lymphotoxin alpha as a new molecular biomarker in revolutionizing tear diagnostic testing for dry eye disease
Chaoran Li
International Journal of Ophthalmology (2023) Vol. 16, Iss. 11, pp. 1883-1889
Open Access
EDITORIAL: Special issue on the Tear Film and the Ocular Surface
Tatiana Maria Suarez-Cortes, Mary Ann Stepp
Experimental Eye Research (2023) Vol. 238, pp. 109705-109705
Closed Access
Page 1

Scroll to top